Results 161 to 170 of about 680,918 (208)
The distinct roles of IL-37 and IL-38 in non-small cell lung carcinoma and their clinical implications. [PDF]
Front ImmunolZhang J, Wise SG, Zuo S, Bao S, Zhang X.
europepmc +1 more source
Molecular advances in early-stage and locally advanced non-small cell lung carcinoma: Shaping the future of precision oncology-systematic review. [PDF]
Sci ProgHassan WA.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Small cell carcinoma of the lung
Critical Reviews in Oncology/Hematology, 1986Small cell lung cancer is a common, usually fatal neoplasm. Although palliative therapy is available for the majority of patients, only a very small minority enjoy long-term survival. Ironically, this neoplasm is nearly entirely preventable and a successful antismoking program is desperately needed.
David H. Johnson +2 more
openaire +2 more sources
Hemophagocytosis by small cell lung carcinoma
American Journal of Hematology, 1991AbstractA 60‐year‐old woman with disseminated small cell carcinoma of the lung and hemophagocytosis by the metastatic cells in the bone marrow is presented, it is the first clinicopathologic report on phagocytosis of erythrocytes by lung tumor cells in concordance with a recently described evidence of a macrophage origin of small cell carcinoma of the ...
Y, Molad +5 more
openaire +2 more sources
Small-Cell Carcinoma of the Lung
Annals of Internal Medicine, 1978Excerpt To the editor: The reports of Weiss (1), Livingston and co-authors (2), and Johnson, Brereton, and Kent (3) clearly indicate an improved prognosis and survival for patients with small-cell ...
J D, Bitran +3 more
openaire +2 more sources
La Revue du praticien, 2003
In most of the cases, small cell lung cancer is diagnosed at the extensive disease stage. Regarding the micrometastatic process, it might be considered as a metastatic disease in almost all cases. Therefore, chemotherapy is the cornerstone of small cell lung cancer therapy. Cisplatin and VP-16-based combinations are recommended.
Jean-Louis, Pujol +5 more
openaire +1 more source
In most of the cases, small cell lung cancer is diagnosed at the extensive disease stage. Regarding the micrometastatic process, it might be considered as a metastatic disease in almost all cases. Therefore, chemotherapy is the cornerstone of small cell lung cancer therapy. Cisplatin and VP-16-based combinations are recommended.
Jean-Louis, Pujol +5 more
openaire +1 more source
Small cell carcinoma of the lung
Cancer Treatment Reviews, 1982Summary The last decade has seen the development of moderately effective therapy for patients with SCAC. When combinations of the most active drugs are employed the majority of patients with both limited and extensive disease can be expected to respond to such therapy.
openaire +2 more sources